Abstract Ovarian cancer is the seventh most common cancer in females worldwide. Optimal debulking is the standard treatment but possible only in 30-85% of advanced stages. Knowing exactly the disease extent preoperatively may predict suboptimal debulking. We analyzed diagnostic accuracy of preoperative CT scan in disease mapping and prediction of suboptimal debulking in a prospective observational study from March 2013 to May 2015 in a tertiary hospital. Adults below the age of 75 years with ECOG PS-0, 1, 2, clinically/radiologically newly diagnosed stage IIIc epithelial ovarian (EOC), and primary peritoneal carcinoma (PPC) were included. Neoadjuvant chemotherapy recipients were excluded. Preoperative multidetector CT (MDCT) scan showing deposits at 19 predetermined abdominopelvic sites were compared with the same sites seen at laparotomy and corresponding accuracies of CT scan calculated. Primary debulking surgery was done to achieve debulking to nil or less than 1-cm residual disease. Stepwise logistic regression models were used to determine the frequent suboptimal debulking sites and the predictive performance of the clinical and CT scan findings. A total of 36 patients were enrolled. The optimal debulking rate was 50%. The CT scan could detect the disease-bearing sites with overall sensitivity of 68.29%, specificity of 89%, accuracy of 78.07%, and positive and negative predictive values of 99 and 50.1%, respectively. Upon multivariate analysis, bowel mesentery (p 0.011) and omental extension (p 0.025) were associated with suboptimal debulking. CT scan accuracy at these sites (predictive performance) was 86.1%. We identified small bowel mesentery and omental extension (to spleen/stomach/colon) as sites associated with suboptimal debulking. MDCT accurately depicts peritoneal metastases, although sensitivity is reduced in certain areas of significance for optimal debulking. Further validation with more number of patients is warranted.
Introduction
Epithelial ovarian cancer (EOC) is the seventh most common cancer in females worldwide and the second commonest gynecological malignancy [1] . A majority of patients (60 to 70%) present at an advanced stage (International Federation of Gynecology and Obstetrics [FIGO] stage III or IV) [2, 3] . Surgical debulking and platinum plus taxane-based chemotherapy are the standard treatments for these advanced cases with long-term cure rates of 20-30% [4, 5] . There is a large evidence demonstrating survival benefit for carcinoma ovary patients who are left with minimal (Boptimal^) residual disease after the debulking procedure [6] , with the recommendations of no gross visible residual disease at the end of debulking surgery [7] .
However, in advanced cases, the rate of optimal cytoreduction at primary debulking surgery varies from 30 to 85% even in expert hands [8] [9] [10] [11] [12] . Patients who undergo suboptimal cytoreduction are at risk of the morbidity and mortality of an extensive surgery without the associated survival benefits. Hence, selection of patients for surgery represents a critical decision-making point in the management of these patients.
A lot of research have evolved in predicting the suboptimal debulking using various parameters like clinical characteristics [13] , diagnostic imaging [14] [15] [16] [17] , laparoscopic findings [18] , and biomarkers such as cancer antigen-125 (CA125) [19] , imaging like computerized tomography (CT scan) [14] [15] [16] [17] 20] , with mixed results, variable applicability, and reproducibility [21, 22] .
The present study prospectively analyzes the accuracy of various preoperative clinicobiochemical and imaging factors to exactly stage the disease distribution and compare this with intraoperative findings so as to predict suboptimal debulking.
Materials and Methods
This is a prospective observational study conducted between March 2013 and May 2015 at a single tertiary care center. Eligibility criteria were Eastern Cooperative Oncology Group performance status (ECOG PS) 0, 1, 2 and aged between 18 and 75 years with clinically diagnosed stage IIIc epithelial ovarian, fallopian tube, or primary peritoneal carcinoma (PPC) who were planned for primary debulking surgery. Patients were excluded if they had other cause of carcinomatosis; if they did not have advanced disease; or if they received neoadjuvant chemotherapy.
The schema of the study was as per the following steps:
1. Recording of preoperative demography and laboratory values. 2. Detailed recording of preoperative CT scan findings of disease distribution at 19 predetermined sites. 3. Detailed intraoperative assessment of disease distribution at 19 predetermined sites. 4. Correlation of the preoperative CT scan findings and the intraoperative findings of disease distribution (Objective 1). 5. Correlation of the intraoperative disease distribution and the rate of optimal/suboptimal debulking (identifying the sites of residual disease) (Objective 2). 6. Assessment of prediction of suboptimal debulking by preoperative clinical, laboratory, and imaging factors (Primary aim).
Preoperative CT Scans
CT scans were performed with a high-speed scanner-Siemens Somatom Sensation 64-slice MDCT (Siemens Medical Systems, Iselin, NJ). After oral administration, 40 ml of 2% Gastrografin contrast in 2 l of water, a CT scan was obtained at baseline and 30 s after intravenous administration of 80 ml of nonionic contrast at 2.3 ml/s rate. Images were obtained with 3-5 mm thickness and 15 mm/s table speed.
All the preoperative CT scans were systematically reviewed by the assigned radiologists before surgery who were blinded for the clinical decision of the treatment. The 19 potential sites of metastatic deposits included were the right and left subdiaphragms, right and left paracolic regions, small and large bowel serosa, small and large bowel mesenteries, omental cake extension (to splenic hilum, stomach, colon, or lesser sac), parietal peritoneum, pelvic peritoneum, liver, spleen surface, porta hepatis, diffuse peritoneal thickening, retroperitoneal lymph nodes larger than 1 cm, and largevolume ascites. Large-volume ascites was defined as the presence of ascites on two thirds or more of abdominopelvic CT scan cuts. By omental extension, we mean omental cake extending and involving the spleen, stomach, lesser sac, or transverse colon requiring multivisceral resection to achieve optimal debulking. As described by Dowdy et al. [15] , diffuse peritoneal thickening was defined as peritoneal thickening to 4 mm involving at least two of the five following areas: lateral paracolic gutters, lateral conal fascia, anterior abdominal wall, diaphragm, and pelvic peritoneal reflections. It was technically difficult to count the number of peritoneal deposits on CT scans and during surgery when there was diffuse carcinomatosis. Hence, while tabulating the findings, the presence of peritoneal deposits >2 cm in size in the respective sites was considered irrespective of actual number.
Surgical Management
All the patients were counseled regarding the nature of the surgery and possible complications. All the patients gave written consent for the study. The study was approved by the ethical committee of the institution.
All surgeries were performed within 2 weeks after the CT scan by three gynecologic oncologists. Standard procedures included midline laparotomy, surgical findings of disease distribution like site, size, pattern, and number of deposits (if countable) were recorded before starting of debulking; extrafascial hysterectomy, bilateral salphingo-oophorectomy, infragastric omentectomy, and systematic pelvic and paraaortic lymphadenectomy (only if complete tumor resection is possible at other sites). Optimal cytoreduction was defined as nil or less than 1-cm residual disease. Radical surgeries were done as appropriate to achieve optimal debulking.
The standard of reference for imaging and surgical findings was determined by combining each patient's surgical and histopathological findings.
Statistical Analysis
The chi square (X 2 ) test was used to test the statistical significance of the association between preoperative clinical factors with the rate of optimal/suboptimal debulking. Validity parameters of preoperative CT scan compared to intraoperative findings were calculated for each site. The significance of the association between the operative findings of disease-bearing sites and optimal debulking rate was calculated with the chi square (X 2 ) test. Univariate and multivariable stepwise logistic regression models were used to determine the disease sites most frequently associated with suboptimal debulking. The level of significance was kept as 0.05.
Results
We analyzed 36 consecutive patients of stage IIIc epithelial ovarian and PPC undergoing primary debulking surgery on the basis of the eligibility criteria. Diagnosis and staging of all the patients were confirmed as per final pathological examinations. Patient and disease characteristics are shown in Table 1 .
The mean age at presentation was 51 years (range of 39-74 years). The ECOG-PS of 0 and 1, and 2 was seen in 30 (83.3%) and 6 (16.7%), respectively. Most patients (88%) presented with nonspecific complaints (abdominal vague pains, insignificant weight loss, abdominal distension, bloating, and early satiety). Severe abdominal pain in three (8.3%) and intestinal obstruction in one patient was seen at initial presentation. Clinically gross ascites was diagnosed in 26 (72.3%) patients and palpable abdominal mass in 18 patients (50%). Upon final histopathological examination, primary ovarian carcinoma and PPC were diagnosed in 31 (86%) and 5 (14%), respectively. The most common histology was serous papillary adenocarcinoma (55.5%). High-grade and low-grade lesions were seen in 27 (75%) and 9 (25%), respectively. All patients except one had raised CA125 (range 31 to 29,910 kU/l, median 702 kU/l). A CA125 of more than the cutoff for our study (500) was present in 19 (53%) patients.
At the end of the primary debulking surgery, optimal debulking to residual disease of less than or equal to 1 cm was achieved in 18 (50%) patients, out of which, debulking to no residual disease was possible in ten patients (27.7%). Average duration of surgery was 240 min (60-480 min). Average blood loss was 316 ml (110-900 ml) with an average 1.7 units of blood transfusion requirement. Additional complex procedures in the form of rectosigmoid resection (four), small bowel resection (three), splenectomy (three), and peritoneal stripping (seven) were done to achieve optimal debulking (total 47%). In six patients, surgery could not be completed due to intraoperative unstability (two) and anticipated suboptimal debulking due to extensive carcinomatosis upon initial surgical evaluation (four).
The rate of postoperative complications was 25%, these were reexploration for intraabdominal bleeding (one), postoperative chest congestion and lower respiratory tract infection (four), and wound infection (three). There was no mortality within 30 days after surgery.
Correlation of Clinical Factors with Debulking Rate
Clinically detected gross ascites was the only clinical factor associated with suboptimal debulking. p 0.050 on univariate analysis. No other factor like age, ECOG PS, CA125, histology, or grade was correlated with the surgical outcome. Patients with clinically detected gross ascites also had the simultaneous presence of disease at other sites like right subdiaphragmatic region (100%), left subdiaphragmatic region (81%), liver surface (73%), porta hepatic (69%), parietal peritoneum (80%), omental extension (69%), and small bowel mesentery (61.5%). The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy for this clinical parameter in predicting suboptimal debulking result was 88.8, 44.4, 61.5, 80, and 66.6%, respectively.
Results of Objective 1 (Accuracy of CT Scan in Detection of Sites of Disease)
The correlation of the accuracy of CT scan findings of the sites of disease with respect to intraoperative findings is shown in Table 2 . Diffuse peritoneal thickening on the CT scan matched with the operative findings with 100% accuracy. The CT scan has high sensitivity in diagnosing deposits at both subdiaphragmatic regions, omentum, and retroperitoneal nodes (>80% sensitivity) whereas the CT scan's sensitivity in diagnosing disease at bowel serosa, mesentery, and porta hepatis was low (35 to 53%).
Results of Objective 2 (Analysis of intraoperatively Identified Sites and Pattern of Disease with the Rate of Suboptimal Debulking)
The univariate and multivariate analyses are shown in Table 3 . Multivariate analysis showed deposits at small bowel mesentery (p 0.011) and presence of omental extension (to spleen/stomach/colon/lesser sac) (p 0.025) as consistent with the suboptimal debulking rate. There is a trend towards significance for clinical ascites.
Discussion
This study reports the results from a prospective trial investigating the role of preoperative clinical and CT scan-based evaluation in the preoperative prediction of optimal debulking in advanced epithelial ovarian and primary peritoneal cancer. In the present study, among the clinical factors, only clinically detected gross ascites was found to be significantly associated with suboptimal debulking (p 0.050). This is consistent with the theory of peritoneal carcinomatosis which is induced and propagated by ascitic fluid [23] . In a clinical study, Brockbank EC et al. [24] observed clinically diagnosed ascites along with other clinical parameters to be associated with suboptimal outcome. Eisenkop SM et al. [8] also demonstrated ascites of more than 1 l to be associated with suboptimal debulking.
Goff BA et al. [25] have observed symptoms, such as abdominal pain, abdominal distension and bloating, and early satiety as indicative of more advanced diseases especially upper abdominal disease. Such symptoms were present in 88% of our patients. But this parameter and other clinical factors like age, ECOG PS, CA125, histology, and tumor grade were not associated with surgical outcome. However, Aletti GD et al. [26] has cautioned the use of clinical factors in predicting surgical results in view of variable surgeon's experience and ability in approaching the debulking surgery. Still, these findings may at least give an indication of the presence of an advanced disease and the surgeon can be prepared for further investigations and possible extensive surgery.
In the present study, the CT scan imaging could identify the disease at different locations as confirmed on surgical exploration with overall sensitivity of 68.29%, specificity of 89%, PPV of 99%, NPV of 50.1%, and accuracy of 78.07%. The highest detection rate was seen for the diffuse peritoneal thickening (100% sensitive) and lymph nodal region (94%) followed by the subdiaphragmatic region (91.6%) and omental extension (75%) ( Table 2 ). This is comparable to the results of a prospective study by G Ferrandina et al. [27] where the accuracy of the CT scan in identification of sites of disease was 78.5% for diffuse peritoneal thickening, 79.2% for omental extension to spleen or stomach, 81.9% for infrarenal lymph nodes, and 67% for subdiaphragmatic deposits.
In the present study, the sensitivity was 72.5% for identifying deposits at upper abdominal sites (both subdiaphragmatic regions, liver, spleen, lesser sac, porta hepatis) ( Fig. 1) and a low sensitivity was noted for bowel serosa and mesentery (35 to 53%) sites. These results are consistent with a similar study by Chandrashekhara et al. [28] where the sensitivity of the CT scan in finding the disease at upper abdominal sites was 74.8% compared to low sensitivity (33.3%) for the umbilical region (presumably the mesentery and bowel serosa). Table 4 shows previous studies showing the overall accuracy of CT scan in locating important disease-bearing sites.
In the present study, high specificity and positive predictive value of CT scan for the diagnosis of peritoneal metastases sites indicating that the rate of CT scan detected lesions being positive for metastasis is high.
Mere presence of omental cake can be resected in almost all the cases. But when the omental disease spreads to involve surrounding organs like transverse colon, lesser sac, stomach, spleen hilum or porta, it becomes difficult to resect and may need multivisceral resection to achieve optimal debulking. Similarly, multiple, large deposits at the root of mesentery precludes optimal debulking. Hence, finding disease at these two sites preoperatively or at the beginning of the surgery will predict the ultimate suboptimal outcome and avoid unnecessary debulking surgery with associated morbidity and mortality. Patients with this type of extensive disease may be treated with neoadjuvant chemotherapy followed by interval debulking surgery which is claimed to downstage the disease and gives comparable survival results to primary debulking surgery [32] . The accuracy of CT scan in identifying these two sites in our study was comparable to previous studies as shown in Table 5 . The strengths of the study are as follows: This is a prospective study. Use of multidetector CT scan machine with thin cuts made easy and fairly accurate interpretation of the disease distribution. A different observation was made in this study about the pattern of disease like nodular, plaque-like, or granular type of deposits which is easy to identify intraoperatively (or by diagnostic laparoscopy). We could identify clinical factors like clinically detectable gross ascites which in association with other factors may predict suboptimal debulking. This particular finding which can be assessed on the first patient visit itself can give an indication for more thorough metastatic work-up and preparedness for extensive surgery.
A fewer number of patients can be a limiting factor in our study which precludes us from doing extensive analysis or proposing some index or model for predicting the surgical outcome. Nevertheless, we could show a few sites in the abdomen which are demonstrable on CT scan that are consistent with suboptimal surgical results. The debulking rate was low (50%). The reasons could be the low rate of radical procedures done (47%) to achieve optimal debulking and inability to complete the surgery in six patients due to not attempting debulking in anticipation of suboptimal debulking upon initial surgical staging evaluation (four patients) and due to intraoperative unstability (two patients), thus underlines the importance of patient selection and surgical expertise.
Conclusions
We identified two peritoneal metastatic sites in the abdomensmall bowel mesentery and omental extension (to spleen, stomach, colon, lesser sac, or colon) which are associated with suboptimal debulking. MDCT scan is accurate in the depiction of peritoneal metastases, although sensitivity is reduced in certain areas of significance for optimal debulking. Clinically detected gross ascites can be a first indication of a more extensive disease. A further study with more patients is warranted to more precisely draw conclusions.
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